Predominance of CK2α over CK2α' in the mammalian brain
- PMID: 21761202
- DOI: 10.1007/s11010-011-0963-6
Predominance of CK2α over CK2α' in the mammalian brain
Abstract
CK2 is a heterotetrameric ubiquitous kinase consisting of two catalytic subunits and two regulatory subunits. The two catalytic subunits, α and α', are highly homologous but differ in their C-terminal regions. It is not known whether CK2α and α' have distinctive substrate specificity, since no α- or α'-specific substrate has been identified. Thus, it is assumed that the two kinase isoforms overlap in their substrate specificity. CK2 protein levels and activity were found to be elevated in the brain when compared to other organs. Here we have studied the protein levels of CK2α and α' isoforms in nine major brain regions. We found that both, CK2α and α', are expressed in all brain regions tested. Whereas CK2α levels do not vary strongly across the regions, CK2α' levels are slightly higher in the cortex and hippocampus than in other regions. Furthermore, we show that CK2α protein levels in the striatum are relatively high when compared to CK2α'. The approximate stoichiometry ratio of CK2α:CK2α' is 8:1. Therefore, one can consider that CK2α levels are predominant in comparison to CK2α' levels throughout the mammalian brain.
Similar articles
-
Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.J Pharm Biomed Anal. 2016 Mar 20;121:253-260. doi: 10.1016/j.jpba.2016.01.011. Epub 2016 Jan 8. J Pharm Biomed Anal. 2016. PMID: 26786382
-
Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.Mol Cell Biochem. 2008 Sep;316(1-2):37-47. doi: 10.1007/s11010-008-9824-3. Epub 2008 Jun 24. Mol Cell Biochem. 2008. PMID: 18574672
-
Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.Cell Tissue Res. 2009 Oct;338(1):139-49. doi: 10.1007/s00441-009-0847-1. Epub 2009 Aug 27. Cell Tissue Res. 2009. PMID: 19711102
-
Protein Kinase CK2α', More than a Backup of CK2α.Cells. 2023 Dec 14;12(24):2834. doi: 10.3390/cells12242834. Cells. 2023. PMID: 38132153 Free PMC article. Review.
-
Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.Cell Mol Life Sci. 2009 Jun;66(11-12):1800-16. doi: 10.1007/s00018-009-9149-8. Cell Mol Life Sci. 2009. PMID: 19387553 Free PMC article. Review.
Cited by
-
Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.Hum Genet. 2021 Jul;140(7):1077-1096. doi: 10.1007/s00439-021-02280-5. Epub 2021 May 4. Hum Genet. 2021. PMID: 33944995
-
Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome-Two Sides of the Same Coin?Front Mol Biosci. 2022 May 26;9:850559. doi: 10.3389/fmolb.2022.850559. eCollection 2022. Front Mol Biosci. 2022. PMID: 35693553 Free PMC article. Review.
-
CK2-An Emerging Target for Neurological and Psychiatric Disorders.Pharmaceuticals (Basel). 2017 Jan 5;10(1):7. doi: 10.3390/ph10010007. Pharmaceuticals (Basel). 2017. PMID: 28067771 Free PMC article. Review.
-
Missense mutation in the activation segment of the kinase CK2 models Okur-Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapse.Mol Psychiatry. 2025 Apr;30(4):1497-1509. doi: 10.1038/s41380-024-02762-8. Epub 2024 Oct 4. Mol Psychiatry. 2025. PMID: 39367055
-
CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.Epilepsia. 2021 Jul;62(7):e103-e109. doi: 10.1111/epi.16931. Epub 2021 May 26. Epilepsia. 2021. PMID: 34041744 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources